CLEXBIO
ClexBio, we envision a world where no patient needs to die while waiting for an organ transplant.
CLEXBIO
Social Links:
Industry:
Health Care
Founded:
2020-01-01
Address:
Oslo, Oslo, Norway
Country:
Norway
Website Url:
http://www.clexbio.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
2.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Amazon Google Apps For Business Cloudflare JS CDN JS AJAX Libraries API
Similar Organizations
Braive
Braive develops and delivers online-based Cognitive Behavioural Therapy (CBT) treatment programs for healthcare, businesses and individuals.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Habitual
Digital therapeutics & nutritional treatment for type 2 diabetes reversal.
Hoth Intelligence
Seeing is everything. We use augmented reality to make healthcare better.
Push Doctor
Push Doctor is creating the future of healthcare.
Current Employees Featured
Founder
Official Site Inspections
http://www.clexbio.com
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "ClexBio"
ClexBio | Engineering Human Tissue Transplants
ClexBio is a biotech company creating innovative solutions for tissue engineering and single-cell techniques using advanced microfluidics and the proprietary CLEX hydrogel technology.See details»
ClexBio - Crunchbase Company Profile & Funding
ClexBio is a pre-clinical stage regenerative medicine company that has developed a ground-breaking proprietary technology platform for scalable, high-throughput tissue generation. …See details»
ClexBio - Lab Manager
Jul 9, 2021 ClexBio ClexBio is a Norway-based biotech company creating breakthrough solutions for tissue engineering and single-cell techniques by combining advanced …See details»
ClexBio | Next-Generation Tissue Therapeutics
ClexBio is a pre-clinical tissue therapeutics company with a next-generation technology platform enabling scalable, high-throughput generation of bioengineered tissues. TECHNOLOGy. …See details»
ClexBio Company Profile 2024: Valuation, Funding & Investors
ClexBio General Information Description. Developer of regenerative implants intended to develop bioengineered human blood vessels for transplant. The company utilizes tissue engineering …See details»
ClexBio - LinkedIn
ClexBio is a preclinical-stage regenerative medicine company with a breakthrough platform for scalable, high-throughput generation of therapeutic tissues.See details»
ClexBio - Products, Competitors, Financials, Employees, …
ClexBio envisions bioengineering producing various medical treatments. “In the future, we believe tissue therapeutic solutions will provide a cure for many of the chronic conditions that are …See details»
ClexBio Company Profile - Office Locations, Competitors ... - Craft
ClexBio (also known as Nordovo Biosciences AS) is a biotech company creating solutions for tissue engineering and single-cell techniques by combining bio-fabrication approaches with its …See details»
ClexBio - Company Profile - Tracxn
Aug 4, 2024 ClexBio - Developer of microfluidic chip for laboratory purposes. Raised a total funding of $1.2M over 2 rounds from 5 investors. Founded by Armend G Hati and Manuel …See details»
EQT Foundation backs ClexBio, transforming the future of tissue ...
Nov 22, 2024 EQT Foundation joins a funding round for ClexBio to accelerate the development of bioengineered tissues ClexBio’s proprietary platform offers a new approach to creating …See details»
ClexBio Company Profile: Overview and Full News Analysis
ClexBio is a regenerative medicine company based in Oslo, operating in the pre-clinical stage with a revolutionary proprietary technology platform for scalable and high-throughput tissue …See details»
ClexBio - Contacts, Employees, Board Members, Advisors & Alumni
ClexBio, we envision a world where no patient needs to die while waiting for an organ transplant.See details»
ClexBio | EU-Startups
ClexBio is a biotech company creating breakthrough solutions for tissue engineering and single-cell techniques by combining advanced microfluidics with our proprietary hydrogel technology …See details»
About Us | Next-Generation Tissue Therapeutics - clexbio.com
ClexBio is a pre-clinical stage regenerative medicine company with a breakthrough proprietary technology platform for scalable, high-throughput tissue generation.See details»
ClexBio – NOME
ClexBio ClexBio creates breakthrough solutions for tissue engineering and single-cell techniques by combining advanced microfluidics with its proprietary hydrogel technology CLEX. CLEX is …See details»
ClexBio Website_v02
ClexBio’s multi-component approach holds promise for treating a wide range of chronic diseases, which the company is aiming to scale into a multi-indication tissue therapy platform. ... About …See details»
This startup is bioengineering tissue into human vein implants
Feb 23, 2024 Norwegian startup ClexBio is bioengineering human veins to implant inside a patient’s body. Together with CSEM, a Swiss R&D centre, the company has built a prototype …See details»
Technology - clexbio.com
Our VivoSetâ„¢ tissue engineering technology provides ideal conditions for co-culture of human cells to create anatomical features found in the body, such as microvasculature and …See details»
Recent News - clexbio.com
ClexBio Secures Strategic Investments from GG 1978 and EQT Foundation to Advance Next-Generation Tissue Therapeutics. Learn More Learn More. October 1, 2024. Anders Tuv …See details»